These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


175 related items for PubMed ID: 35239032

  • 1. Furosemide and albumin for the treatment of nephrotic edema: a systematic review.
    Hedin E, Bijelić V, Barrowman N, Geier P.
    Pediatr Nephrol; 2022 Aug; 37(8):1747-1757. PubMed ID: 35239032
    [Abstract] [Full Text] [Related]

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 3. Human albumin infusion for treating oedema in people with nephrotic syndrome.
    Ho JJ, Adnan AS, Kueh YC, Ambak NJ, Van Rostenberghe H, Jummaat F.
    Cochrane Database Syst Rev; 2019 Jul 12; 7(7):CD009692. PubMed ID: 31425606
    [Abstract] [Full Text] [Related]

  • 4. Co-administration of albumin-furosemide in patients with the nephrotic syndrome.
    Ghafari A, Mehdizadeh A, Alavi-Darazam I, Rahimi E, Kargar C, Sepehrvand N.
    Saudi J Kidney Dis Transpl; 2011 May 12; 22(3):471-5. PubMed ID: 21566302
    [Abstract] [Full Text] [Related]

  • 5. Treatment of severe edema in children with nephrotic syndrome with diuretics alone--a prospective study.
    Kapur G, Valentini RP, Imam AA, Mattoo TK.
    Clin J Am Soc Nephrol; 2009 May 12; 4(5):907-13. PubMed ID: 19406963
    [Abstract] [Full Text] [Related]

  • 6. Diuretic effect of co-administration of furosemide and albumin in comparison to furosemide therapy alone: An updated systematic review and meta-analysis.
    Lee TH, Kuo G, Chang CH, Huang YT, Yen CL, Lee CC, Fan PC, Chen JJ.
    PLoS One; 2021 May 12; 16(12):e0260312. PubMed ID: 34851962
    [Abstract] [Full Text] [Related]

  • 7. Combined furosemide and human albumin treatment for diuretic-resistant edema.
    Elwell RJ, Spencer AP, Eisele G.
    Ann Pharmacother; 2003 May 12; 37(5):695-700. PubMed ID: 12708949
    [Abstract] [Full Text] [Related]

  • 8. Interventions for minimal change disease in adults with nephrotic syndrome.
    Azukaitis K, Palmer SC, Strippoli GF, Hodson EM.
    Cochrane Database Syst Rev; 2022 Mar 01; 3(3):CD001537. PubMed ID: 35230699
    [Abstract] [Full Text] [Related]

  • 9. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Liu ID, Willis NS, Craig JC, Hodson EM.
    Cochrane Database Syst Rev; 2019 Nov 21; 2019(11):. PubMed ID: 31749142
    [Abstract] [Full Text] [Related]

  • 10. The added-up albumin enhances the diuretic effect of furosemide in patients with hypoalbuminemic chronic kidney disease: a randomized controlled study.
    Phakdeekitcharoen B, Boonyawat K.
    BMC Nephrol; 2012 Aug 29; 13():92. PubMed ID: 22931630
    [Abstract] [Full Text] [Related]

  • 11. Lipid-lowering agents for nephrotic syndrome.
    Kong X, Yuan H, Fan J, Li Z, Wu T, Jiang L.
    Cochrane Database Syst Rev; 2013 Dec 10; (12):CD005425. PubMed ID: 24327265
    [Abstract] [Full Text] [Related]

  • 12. Chinese herbal medicine Huangqi type formulations for nephrotic syndrome.
    Feng M, Yuan W, Zhang R, Fu P, Wu T.
    Cochrane Database Syst Rev; 2013 Jun 05; 2013(6):CD006335. PubMed ID: 23740567
    [Abstract] [Full Text] [Related]

  • 13. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
    Larkins NG, Liu ID, Willis NS, Craig JC, Hodson EM.
    Cochrane Database Syst Rev; 2020 Apr 16; 4(4):CD002290. PubMed ID: 32297308
    [Abstract] [Full Text] [Related]

  • 14. Current Perspectives in Management of Edema in Nephrotic Syndrome.
    Meena J, Bagga A.
    Indian J Pediatr; 2020 Aug 16; 87(8):633-640. PubMed ID: 32232733
    [Abstract] [Full Text] [Related]

  • 15. Interventions for focal segmental glomerulosclerosis in adults.
    Hodson EM, Sinha A, Cooper TE.
    Cochrane Database Syst Rev; 2022 Feb 28; 2(2):CD003233. PubMed ID: 35224732
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and Safety of Combination Therapy with Tolvaptan and Furosemide in Children with Nephrotic Syndrome and Refractory Edema: A Prospective Interventional Study.
    Meena J, Hari P, Sinha A, Bagga A.
    Indian J Pediatr; 2022 Jul 28; 89(7):699-705. PubMed ID: 35080742
    [Abstract] [Full Text] [Related]

  • 17. Altered dietary salt intake for preventing diabetic kidney disease and its progression.
    Hodson EM, Cooper TE.
    Cochrane Database Syst Rev; 2023 Jan 16; 1(1):CD006763. PubMed ID: 36645291
    [Abstract] [Full Text] [Related]

  • 18. Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
    von Groote TC, Williams G, Au EH, Chen Y, Mathew AT, Hodson EM, Tunnicliffe DJ.
    Cochrane Database Syst Rev; 2021 Nov 15; 11(11):CD004293. PubMed ID: 34778952
    [Abstract] [Full Text] [Related]

  • 19. Corticosteroid therapy for nephrotic syndrome in children.
    Hahn D, Hodson EM, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2015 Mar 18; 2015(3):CD001533. PubMed ID: 25785660
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of furosemide-albumin compared with furosemide in critically ill hypoalbuminemia patients admitted to intensive care unit: a prospective randomized clinical trial.
    Mahmoodpoor A, Zahedi S, Pourakbar A, Hamishehkar H, Shadvar K, Asgharian P, Shahabi F, Hamishehkar H.
    Daru; 2020 Jun 18; 28(1):263-269. PubMed ID: 32291620
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.